Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Mar 27, 2025; 17(3): 100763
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.100763
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.100763
Table 1 Baseline characteristics of patients before and after propensity score matching, n (%)
Characteristic | Before matching | After matching | ||||
Diabetic (n = 300) | Non-diabetic (n = 900) | P value | Diabetic (n = 280) | Non-diabetic (n = 280) | P value | |
Age (years) | 68.5 ± 9.2 | 63.7 ± 11.3 | < 0.001 | 67.8 ± 9.5 | 67.3 ± 10.1 | 0.54 |
Male sex | 190 (62.9) | 536 (59.0) | 0.22 | 172 (61.4) | 169 (60.4) | 0.80 |
BMI (kg/m²) | 26.3 ± 4.1 | 24.8 ± 3.7 | < 0.001 | 25.9 ± 3.9 | 25.7 ± 3.8 | 0.53 |
Hypertension | 187 (61.9) | 372 (41.0) | < 0.001 | 168 (60.0) | 165 (58.9) | 0.79 |
CVD | 85 (28.1) | 154 (17.0) | < 0.001 | 75 (26.8) | 72 (25.7) | 0.77 |
Tumor stage | 0.18 | 0.95 | ||||
I | 70 (23.2) | 236 (26.0) | 66 (23.6) | 68 (24.3) | ||
II | 93 (30.8) | 300 (33.0) | 89 (31.8) | 87 (31.1) | ||
III | 139 (46.0) | 372 (41.0) | 125 (44.6) | 125 (44.6) |
Table 2 Incidence of specific postoperative complications in diabetic and non-diabetic patients, n (%)
Complication | Diabetic (n = 280) | Non-diabetic (n = 280) | P value |
Surgical site infection | 44 (15.7) | 25 (8.9) | 0.015 |
Pneumonia | 35 (12.5) | 20 (7.1) | 0.037 |
Urinary tract infection | 26 (9.3) | 13 (4.6) | 0.029 |
Anastomotic leakage | 17 (6.1) | 11 (3.9) | 0.241 |
Deep vein thrombosis | 9 (3.2) | 5 (1.8) | 0.281 |
Table 3 Mean quality of life scores at 3, 6, and 12 months following surgery, mean ± SD
Domain | Time point | Diabetic | Non-diabetic | Mean difference (95%CI) | P value |
Physical functioning | 3 months | 65.2 ± 18.7 | 73.5 ± 16.9 | -8.3 (-11.7 to -4.9) | < 0.001 |
6 months | 71.8 ± 17.3 | 78.9 ± 15.6 | -7.1 (-10.2 to -4.0) | < 0.001 | |
12 months | 75.6 ± 16.1 | 81.2 ± 14.8 | -5.6 (-8.5 to -2.7) | < 0.001 | |
Fatigue | 3 months | 43.7 ± 22.4 | 36.5 ± 20.1 | 7.2 (4.1 to 10.3) | < 0.001 |
6 months | 38.9 ± 20.8 | 33.1 ± 18.7 | 5.8 (2.9 to 8.7) | < 0.001 | |
12 months | 35.2 ± 19.5 | 30.8 ± 17.9 | 4.4 (1.7 to 7.1) | 0.002 | |
Pain | 3 months | 32.8 ± 24.6 | 26.3 ± 22.1 | 6.5 (3.2 to 9.8) | < 0.001 |
6 months | 28.5 ± 22.9 | 23.7 ± 20.8 | 4.8 (1.7 to 7.9) | 0.003 | |
12 months | 25.1 ± 21.3 | 21.4 ± 19.5 | 3.7 (0.8 to 6.6) | 0.013 | |
Reflux symptoms | 3 months | 26.9 ± 22.7 | 21.1 ± 19.8 | 5.8 (2.7 to 8.9) | 0.002 |
6 months | 24.3 ± 21.1 | 19.8 ± 18.5 | 4.5 (1.6 to 7.4) | 0.004 | |
12 months | 22.7 ± 20.3 | 18.9 ± 17.9 | 3.8 (1.1 to 6.5) | 0.006 | |
Eating restrictions | 3 months | 38.6 ± 24.9 | 31.5 ± 22.3 | 7.1 (3.9 to 10.3) | < 0.001 |
6 months | 34.2 ± 23.1 | 28.7 ± 20.8 | 5.5 (2.5 to 8.5) | < 0.001 | |
12 months | 31.3 ± 21.7 | 26.9 ± 19.5 | 4.4 (1.6 to 7.2) | 0.002 |
- Citation: Zhao L, Wei L, Fei XL. Impact of diabetes on recovery after radical gastrectomy for gastric cancer: A retrospective cohort study. World J Gastrointest Surg 2025; 17(3): 100763
- URL: https://www.wjgnet.com/1948-9366/full/v17/i3/100763.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i3.100763